Showing results (561-570 of 640) with videos related to
Sort By:
Pageof 64
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-upP K Schultz, H W Herr, Z F Zhang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional studyD F Bajorin, M F Sarosdy, D G Pfister, et al.International Journal of Cancer|March 25, 2006
Cyclooxygenase-2 (COX-2) expression is an independent predictor of prostate cancer recurrenceBrian L Cohen, Pablo Gomez, Yohei Omori, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 1, 1992
Quality of life and psychosocial status in stage D prostate cancer. Zoladex Prostate Cancer Study GroupB R Cassileth, M S Soloway, N J Vogelzang, et al.Urology|May 1, 1989
Patients' choice of treatment in stage D prostate cancerB R Cassileth, M S Soloway, N J Vogelzang, et al.Urology|February 7, 2007
Muscle-invasive urothelial carcinoma of the bladderS Bruce Malkowicz, Hendrik van Poppel, Gerald Mickisch, et al.Critical Reviews in Oncology/Hematology|February 1, 1994
Bladder cancer: advances in biology and treatmentG J Bosl, W R Fair, H W Herr, et al.World Journal of Urology|February 2, 2010
Contemporary open partial nephrectomy is associated with diminished procedure-specific morbidity despite increasing technical challenges: a single institutional experienceBruce R Kava, Rosely De Los Santos, Rajinikanth Ayyathurai, et al.The Journal of Urology|March 1, 1988
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumorsH I Scher, A Yagoda, H W Herr, et al.The Journal of Urology|May 16, 2012
Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopyH Barton Grossman, Arnulf Stenzl, Yves Fradet, et al.Pageof 64